-

EvoEndo Introduces Additional Gastroscope for Sedation-Free TNE

New Model LE 85 Single-Use Gastroscope added to the EvoEndo Endoscopy System —

DENVER--(BUSINESS WIRE)--EvoEndo®, Inc. (EvoEndo) is excited to announce the release of the Model LE 85 Single-Use Gastroscope, providing an additional option for Sedation-Free Transnasal Endoscopy (TNE) of the Upper Gastrointestinal Tract.

"We are committed to expanding our platform of ultra-slim endoscopes offering sedation-free TNE for adults and children." - Jonathan Hartmann, EvoEndo Chief Executive Officer

Share

The Model LE 85 Single-Use Gastroscope is designed to offer maximum patient comfort and physician control when access to the duodenum is not required. It features a shorter shaft length and enhanced flexibility while maintaining all the functionality of the Model LE 110 Single-Use Gastroscope. Physicians can now choose the scope length most suitable for each procedure.

Paul Tran, MD, a pediatric gastroenterologist in Phoenix, AZ, shared, "I volunteered to scope myself as part of an educational event and was surprised at how comfortable the Model LE 85 Gastroscope was. The flexibility of the 85 cm is excellent, while the 110 cm enables me to do a full EGD when necessary. Perfect combo!"

“Our commitment to integrating physician and patient feedback leads to the next generation of product functionality and performance,” explained Paul Imaoka, EvoEndo Senior Vice President of Manufacturing & Operations. He continued, “Rapid, iterative development is the result of strong engineering, a deep knowledge of the application, and a sense of urgency to meet clinical needs.”

Since the FDA cleared the EvoEndo Model LE 110 Single-Use Gastroscope in February 2022, two upgraded models have been released that provide enhanced imaging, ergonomics, and steering. Today’s introduction of the Model LE 85 Single-Use Gastroscope elevates the EvoEndo Endoscopy System’s capabilities and expands clinical indications, underscoring EvoEndo’s dedication to evolving endoscopy.

EvoEndo's Chief Executive Officer, Jonathan Hartmann, stated, “Our team is driving innovation to provide patients, families, and physicians with safe and effective devices that enable successful procedures while ensuring the most comfortable experience possible.” He added, “EvoEndo is proud to launch the Model LE 85. We are committed to expanding our platform of ultra-slim endoscopes offering sedation-free TNE for adults and children.”

About EvoEndo®

EvoEndo is the only medical device company dedicated to pediatric (age 5+) gastroenterology patients and designed the EvoEndo Single-Use Endoscopy System for small anatomy and sedation-free procedures.

At EvoEndo, we achieve big things through small scopes. Our ultra-slim technology unleashes the potential of sedation-free endoscopy to improve the lives of patients, families, and healthcare professionals.

The EvoEndo® Model LE Gastroscope is intended for the visualization of the upper digestive tract in adults and pediatric patients, specifically for the observation, diagnosis, and endoscopic treatment of the esophagus, stomach, and duodenal bulb in patients over the age of five. The gastroscope is a sterile, single-use device and can be inserted orally or transnasally. The EvoEndo® Controller is intended for use with an EvoEndo® Endoscope for endoscopic diagnosis, treatment, and video observation.

To learn more, please visit https://evoendo.com.

Contacts

Paula Rocha
procha@evoendo.com
303.276.5753

More News From EvoEndo, Inc.

EvoEndo® Expands Access to Sedation-Free Endoscopy Across Gastroenterology Programs of All Sizes

CHICAGO--(BUSINESS WIRE)--EvoEndo®, Inc. (EvoEndo) today announced that sedation-free transnasal endoscopy (TNE) is reaching a broader range of gastroenterology programs, including clinic settings without dedicated anesthesia coverage or operating room access. Because the EvoEndo Endoscopy System does not require sedation, programs of nearly any size can offer diagnostic evaluation and monitoring in their own clinic setting. “A sedation-free alternative to traditional endoscopy changes where ca...

EvoEndo® Surpasses 3,000 Sedation-Free Transnasal Endoscopy Procedures Nationwide

CHICAGO--(BUSINESS WIRE)--EvoEndo®, Inc. (EvoEndo) today announced that practitioners have now completed more than 3,000 sedation-free transnasal endoscopy (TNE) procedures using the EvoEndo Endoscopy System, as implementation expands to more than 70 locations nationwide. “Reaching 3,000 cases is an important milestone, but what matters most is what it represents for patients, families, and physicians,” said Jonathan Hartmann, CEO of EvoEndo. “Every case reflects greater access to sedation-free...

Nicklaus Children's Hospital is First in Region to Offer Sedation-Free Evaluation of Upper Gastrointestinal Tract in Children

DENVER--(BUSINESS WIRE)--EvoEndo®, Inc. (EvoEndo) announces that Nicklaus Children’s Hospital is the first in South Florida to offer sedation-free transnasal endoscopy (TNE) using the EvoEndo System to evaluate the upper digestive tract in children. TNE can be used as an alternative to traditional upper endoscopy performed through the mouth for patients and their families who prefer to avoid sedation and the associated inconveniences. A sedation-free alternative is more convenient for patients...
Back to Newsroom